Navigation Links
Cell and Gene Therapy: Taking a New Facility from Construction to Production, Upcoming Webinar Hosted by Xtalks
Date:2/21/2020

Join Forrest Brown, Engineering Services Manager – Northeast Region and Jarred Christofaro, Engineering Services Manager – Southeast Region of Sequence, Inc. for an informative session on Wednesday, February 26, 2020 at 1pm EST to learn about:

  • Design Flexibility: Key elements to incorporate into facility design to add manufacturing flexibility in the future, especially for CMOs
  • C&Q Strategy Development: Following a risk-based approach is key to delivering a compliant package within tight time constraints. How can you tailor the C&Q to be flexible and fit the needs of multiple clients and/or processes?
  • Scheduling Do’s and Don’ts: How to avoid project delays and how to accelerate certain phases

Cell and Gene Therapy production is one of fastest growing areas in biotechnology. There is increased demand to bring manufacturing spaces online quickly and with enough flexibility to accommodate process changes, especially for contract manufacturers. While this is becoming easier to accomplish through single-use technology and plug-and-play vendor packages, there are certainly pitfalls to navigate to ensure projects are delivered on-time and within budget.

By paying special attention to these 3 items, projects can be delivered more quickly and in a compliant fashion, greatly reducing business risk and ultimately leading to a more profitable operation. Topics of discussion will stem from both direct project experience and industry guidance from organizations such as ISPE. The use of a risk-based approach will be highlighted, as this is one of the most key elements to reducing cost and adhering to schedule. While this oftentimes means early involvement from various groups, establishing risks to the product/process early in the project lifecycle reduce costly design changes and allow for a compliant, hyper-focused C&Q plan which can meet tight schedule constraints. More attention to this at the beginning of a project ultimately saves time at the end when adherence to schedule is much more critical.

Cell and Gene Therapy projects are especially challenging. The cutting-edge nature oftentimes makes for tight timelines, but also requires a lot of flexibility considering how rapidly technology is changing. This impacts all areas of the project lifecycle, and this webinar will discuss some of the areas where key improvements can be made to save time and money.

For more information or to register for this event, visit Cell and Gene Therapy: Taking a New Facility from Construction to Production.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Read the full story at https://www.prweb.com/releases/cell_and_gene_therapy_taking_a_new_facility_from_construction_to_production_upcoming_webinar_hosted_by_xtalks/prweb16926002.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. “Stem Cell Therapy: A Rising Tide - How Stem Cells are Disrupting Medicine and Transforming Lives” - A New Book by Stem Cell Expert, Dr. Neil Riordan, Is On Sale Now
2. VetStem Biopharma CEO and Founder, Dr. Bob Harman, Interviewed in New Book "Stem Cell Therapy: A Rising Tide"
3. 5th Annual "Cancer Immunotherapy: A Long- Awaited Reality" Conference Taking Place March 26, 2015 in New York City
4. Vixiar Medical Taking up Residence at The LaunchPort™ in Port Covington
5. Taking thin films to the extreme
6. John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva
7. Spherix CEO, Anthony Hayes Appears on Bloombergs "Taking Stock With Pimm Fox"
8. Taking a new look at carbon nanotubes
9. Waterloo Heights, a Neighborhood Smiles Dental Practice is Taking a Bold New Approach to the Cavity Epidemic
10. Synagro Awarded City of Fort Worth Contract to Design-Permit-and-Construct Drum Drying Facility
11. Cirtec Medical to Open 30,000 Sq. Ft. Manufacturing Facility in Costa Rica
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/7/2020)... (PRWEB) , ... April 06, 2020 , ... Gateway ... future children, reached 200,000 SneakPeek Early Gender DNA Tests sold in March, ... was launched as an ecommerce product, where a mom could order her kit ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... using its revolutionary NEXTGENPCR endpoint thermocycler and consumables that decreases PCR amplification ... samples per run, and standard, affordable laboratory equipment, a qualitative protocol was ...
(Date:3/27/2020)... , ... March 26, 2020 , ... iFirst Medical Technologies, ... development of COVID-19 nasal swab test. , "COVID-19 poses a grave danger to public ... iFirst. "We at iFirst are compelled to act. Broad-based testing and on-the-spot results promise ...
(Date:3/12/2020)... (PRWEB) , ... March 12, 2020 , ... ... of atomic force microscopy (AFM) technology, increases the business investment in Europe by ... , The Grand Opening Ceremony of the new Nanoscience Center Europe took ...
Breaking Biology Technology:
(Date:5/26/2020)... ... May 26, 2020 , ... Genedata, ... that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, including ... therapeutics, has implemented Genedata Biologics ® within their R&D organization. ...
(Date:5/25/2020)... ... May 22, 2020 , ... Oxford Nanopore Technologies is in advanced ... the virus that causes COVID-19. , The LamPORE assay is designed to ... numbers, to very large numbers of samples. Hardware and reagents sit outside current, ...
(Date:5/21/2020)... (PRWEB) , ... May 21, ... ... Human Capital IntegritySM technology-based services specializing in background and medical screening, announces ... COVID-19 return-to-work planning and keeping their workforce safe. The new service is ...
Breaking Biology News(10 mins):